129 related articles for article (PubMed ID: 25506451)
21. Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study.
Iturralde D; Spaide RF; Meyerle CB; Klancnik JM; Yannuzzi LA; Fisher YL; Sorenson J; Slakter JS; Freund KB; Cooney M; Fine HF
Retina; 2006 Mar; 26(3):279-84. PubMed ID: 16508427
[TBL] [Abstract][Full Text] [Related]
22. Intravitreal triamcinolone acetonide compared with bevacizumab for the treatment of patients with macular edema secondary to central retinal vein occlusion.
Gokce G; Sobaci G; Durukan AH; Erdurman FC
Postgrad Med; 2013 Sep; 125(5):51-8. PubMed ID: 24113663
[TBL] [Abstract][Full Text] [Related]
23. Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema.
Mayer WJ; Remy M; Wolf A; Kook D; Kampik A; Ulbig M; Reznicek L; Haritoglou C
Ophthalmologica; 2012; 228(2):110-6. PubMed ID: 22739239
[TBL] [Abstract][Full Text] [Related]
24. Impending central retinal vein occlusion in patient with idiopathic cutaneous leukocytoclastic vasculitis.
Akhavanrezayat A; Hien DL; Pham BH; Nguyen HV; Tuong Ngoc TT; Al-Moujahed A; Uludag G; Karkhur S; Doan HL; Nguyen QD
Am J Ophthalmol Case Rep; 2020 Dec; 20():100934. PubMed ID: 33015410
[TBL] [Abstract][Full Text] [Related]
25. Sequential anterior ischemic optic neuropathy and central retinal artery and vein occlusion after ranibizumab for diabetic macular edema.
Battaglia Parodi M; Iacono P; Cascavilla ML; Zucchiatti I; Kontadakis DS; Vergallo S; Bandello F
Eur J Ophthalmol; 2010; 20(6):1076-8. PubMed ID: 20954148
[TBL] [Abstract][Full Text] [Related]
26. Central retinal vein occlusion resulting from anomalous retinal vascular anatomy in a 24-year-old man.
Kavoussi SC; Kempton JE; Huang JJ
Clin Ophthalmol; 2015; 9():885-7. PubMed ID: 26056427
[TBL] [Abstract][Full Text] [Related]
27. Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion.
Ip MS; Gottlieb JL; Kahana A; Scott IU; Altaweel MM; Blodi BA; Gangnon RE; Puliafito CA
Arch Ophthalmol; 2004 Aug; 122(8):1131-6. PubMed ID: 15302652
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of dexamethasone intravitreal implant in patients with retinal vein occlusion resistant to anti-VEGF therapy: a 12-month prospective study.
Georgalas L; Tservakis I; Kiskira EE; Petrou P; Papaconstantinou D; Kanakis M
Cutan Ocul Toxicol; 2019 Dec; 38(4):330-337. PubMed ID: 31060385
[No Abstract] [Full Text] [Related]
29. Late hyperbaric oxygen treatment of cilioretinal artery occlusion with nonischemic central retinal vein occlusion secondary to high altitude.
Gokce G; Metin S; Erdem U; Sobaci G; Durukan AH; Cagatay HH; Ekinci M
High Alt Med Biol; 2014 Apr; 15(1):84-8. PubMed ID: 24673536
[TBL] [Abstract][Full Text] [Related]
30. Functional and anatomical results after a single intravitreal Ozurdex injection in retinal vein occlusion: a 6-month follow-up -- the SOLO study.
Bezatis A; Spital G; Höhn F; Maier M; Clemens CR; Wachtlin J; Lehmann F; Hattenbach LO; Feltgen N; Meyer CH
Acta Ophthalmol; 2013 Aug; 91(5):e340-7. PubMed ID: 23638803
[TBL] [Abstract][Full Text] [Related]
31. OUTER RETINAL LAYER CHANGES AFTER DEXAMETHASONE IMPLANT FOR CENTRAL RETINAL VEIN OCCLUSION.
Battaglia Parodi M; Iacono P; Scaramuzzi M; Bandello F
Retina; 2017 Oct; 37(10):1888-1895. PubMed ID: 28030428
[TBL] [Abstract][Full Text] [Related]
32. Macular hole formation and spontaneous closure after vitrectomy for central retinal vein occlusion.
Shukla D; Rajendran A; Kim R
Graefes Arch Clin Exp Ophthalmol; 2006 Oct; 244(10):1350-2. PubMed ID: 16525823
[TBL] [Abstract][Full Text] [Related]
33. Frosted branch angiitis in one eye and impending CRVO in the other: a diagnostic dilemma.
Kumar A; Yangzes S; Singh R
BMJ Case Rep; 2015 Jun; 2015():. PubMed ID: 26055592
[TBL] [Abstract][Full Text] [Related]
34. Short-term results of endovascular surgery with tissue plasminogen activator injection for central retinal vein occlusion.
Ishida M; Abe S; Nakagawa T; Hayashi A
Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2135-2140. PubMed ID: 28803326
[TBL] [Abstract][Full Text] [Related]
35. The outcome of low-frequency intravitreal bevacizumab therapy for macular edema in retinal vein occlusions.
Ivanovska Adjievska B; Boskurt S; Orovcanec N; Dimovska-Jordanova V
Clin Ophthalmol; 2017; 11():1183-1190. PubMed ID: 28790803
[TBL] [Abstract][Full Text] [Related]
36. Sequential Observations of Conversion from Nonischemic to Ischemic Central Retinal Vein Occlusion Using Optical Coherence Tomography Angiography.
Fukutomi A; Tsuboi K; Ono H; Ishida Y; Kamei M
Case Rep Ophthalmol Med; 2018; 2018():1354217. PubMed ID: 29850324
[TBL] [Abstract][Full Text] [Related]
37. Intravitreal bevacizumab injections for treatment of central retinal vein occlusion: six-month results of a prospective trial.
Priglinger SG; Wolf AH; Kreutzer TC; Kook D; Hofer A; Strauss RW; Alge CS; Kunze C; Haritoglou C; Kampik A
Retina; 2007 Oct; 27(8):1004-12. PubMed ID: 18040236
[TBL] [Abstract][Full Text] [Related]
38. Cilioretinal artery occlusion combined with central retinal vein occlusion - a report of two cases and review of the literature.
Theoulakis PE; Livieratou A; Petropoulos IK; Lepidas J; Brinkmann CK; Katsimpris JM
Klin Monbl Augenheilkd; 2010 Apr; 227(4):302-5. PubMed ID: 20408080
[TBL] [Abstract][Full Text] [Related]
39. MACULAR PERIVENOUS RETINAL WHITENING AND PRESUMED RETINO-CILIARY SPARING IN A RECURRENT CENTRAL RETINAL VEIN OCCLUSION ASSOCIATED WITH THE ANTIPHOSPHOLIPID SYNDROME AND CRYOGLOBULINEMIA.
Sebrow DB; Jung JJ; Horowitz J; Odel JG; Freund KB
Retin Cases Brief Rep; 2018 Summer; 12(3):159-165. PubMed ID: 27902540
[TBL] [Abstract][Full Text] [Related]
40. Secondary Coats' response to retinal vasculitis managed with bevacizumab.
Chaudhary P; Varshney A; Videkar C
Indian J Ophthalmol; 2018 Sep; 66(9):1355-1357. PubMed ID: 30127171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
